Welcome to the future of medicine.
At Unlearn, our purpose is to advance artificial intelligence (AI) to eliminate trial and error in medicine. Today, we are reimagining the randomized control trial (RCT) for the 21st century through TwinRCTs. A TwinRCT is an AI-powered RCT that allows more trial patients to receive the experimental treatment and takes significantly less time than a traditional RCT. Unlearn’s innovative work in AI today will reinvent how AI is applied in medicine tomorrow—and we have a
top secret plan for how to get there. We won’t be able to achieve this mission just by applying technologies created by others; the future must be invented.
Unlearn is a technology company, not a biotech company. We use computers, not pipettes. We make and use software, we don’t discover or make drugs. We believe that AI will define the future of medicine, and we aren’t deterred by naysayers or skeptics.
>> Unlearners are disciplined experimenters; we break down our big goals into smaller chunks and meet as often as necessary to track our velocity and iterate quickly.
>> Unlearners are gritty; we never give up, setbacks just make us try harder.
>> Unlearners are receptive to new ideas; in fact, we hate being stuck with the status quo.
>> Unlearners are storytellers; sharing information with each other and with the world is super important, too important to be boring. And, last but not least,
>> Unlearners are team-oriented; we put the mission first, the company second, the team third, and individuals last.
Founded in 2017 by a team of world-class machine learning scientists, we have raised venture capital from top tier investors such as Insight Partners, Radical Ventures, 8VC, DCVC, and DCVC Bio. We completed our $50 million Series B in April 2022. We are headquartered in San Francisco, CA and have an additional office in Boston, MA.
If our purpose and culture resonate with you, please join us.
The Applied Biostatistician drives collaborations with external statistical and technical teams to deliver Unlearn’s cutting-edge TwinRCT, a smaller and more efficient randomized clinical trial.
Responsibilities
- As a Biostatistician, your primary responsibilities are:
- Collaborate with partners (external collaborators) to implement novel methods in clinical trials
- Conduct sample size estimates for trials that will use PROCOVA™
- Identify optimal SAS code for model implementations
- Draft Analysis Plans for trials that use Digital Twins
- Analyze trials following these Analysis Plans using PROCOVA™
- Present to partners on Analysis Plans and analysis results
- Support statistical sections of regulatory submissions
Requirements:
- Masters in Biostatistics or equivalent experience with an advanced degree in a similar field
- At least 2 years of experience in healthcare supporting clinical trials
- Experience writing statistical analysis plans involving linear and non-linear models
- Knowledge of SAS statistical procedures
- Experience with randomized controlled trial study design
We make extensive use of data to ensure all our offers are fair and competitive. Total annual compensation (base salary and performance bonus) for this role will be commensurate with a candidate's experience.
Benefits include:
• 401k plan with generous matching
• Flexible PTO plus company holidays
• Annual company-wide break from December 24 through January 1
• Professional development budget to attend conferences or other events
• Company-subsidized medical, dental, & vision insurance plans
• One-time home-office set-up stipend
• Commuter benefits plan
• Paid Parental Leave
• Salary range: $160k - $190k Unlearn is an equal opportunity employer.
We embrace diversity to create an inclusive work environment because inclusion and diversity are essential to achieving our mission.
All employees who work at Unlearn must comply with our COVID-19 vaccination requirement.
